Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regulus Therapeutics (RGLS) Q2 2024 Earnings
RGLS
+1.32%
9
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.41
-0.35
-0.29
-0.22
Details
Expected EPS
-0.2225
Actual EPS
-0.29
Surprise EPS
-0.07
Surprise Percent
+30.34%
Description
Regulus Therapeutics (RGLS) has reported earnings of -0.29 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login